Patient preference survey for attributes of locally advanced or metastatic urothelial carcinoma treatment in Japan: a discrete-choice experiment

Hiroshi Kitamura, Hiroki Uchida, Yusuke Tanaka, Takeshi Akiyama, Ayumi Morishita, Anzu Yakushiji, Masaya Sakurai · 2025

Read Patient preference survey for attributes of locally advanced or metastatic urothelial carcinoma treatment in Japan: a discrete-choice experiment by Hiroshi Kitamura, Hiroki Uchida, Yusuke Tanaka, Takeshi Akiyama, Ayumi Morishita, Anzu Yakushiji, Masaya Sakurai (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12716548.txt.

Description

Hiroshi Kitamura and co-authors ask Japanese patients with advanced bladder cancer what they value most in treatment, in a 2025 survey. The cancer in question has spread or cannot be removed by surgery, so care aims to extend life while keeping daily life bearable. Patients face hard trade-offs among gains in survival, side effects, and time in hospital.

The survey used a choice method: patients picked between treatment profiles that varied in side effects like nausea, nerve damage, hair loss, and rash, plus hospital stay and length of survival. A math model then weighed how much each trait drove the choices. The results show which gains patients would trade for fewer harms. Drug makers and doctors can use that ranking when they plan and discuss care.

Catalog record

CREATORHiroshi Kitamura, Hiroki Uchida, Yusuke Tanaka, Takeshi Akiyama, Ayumi Morishita, Anzu Yakushiji, Masaya Sakurai
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12716548

Browse the full library · About the Tower of Babel